Considerations for Selection of Fit for-Purpose Data in the US and Japan
Balancing Advantages and Limitations
Before starting your real-world evidence (RWE) study, the choice of data is critical. Each option—whether administrative claims, electronic medical records, registries, or surveys—offers unique strengths and limitations. Selecting the right one depends on your research objectives and the nuances of the healthcare system where the data originates.
What You’ll Learn in This White Paper:
An Overview of Data Sources: Understand the four key categories of RWE data sources and when to use each.
Linked Data Assets: Explore how combining datasets can overcome limitations and enhance research quality.
Healthcare System Context: Gain insights into the healthcare ecosystems of the United States and Japan, including payer types, patient pathways, and common data sources.
GIPAM’s Expertise: Learn about our approach to identifying and evaluating fit-for-purpose data sources through rigorous feasibility and landscaping studies, supported by our proprietary database tool.
Why This Matters:
Choosing the wrong data source can compromise your study outcomes. This white paper equips you with the foundational knowledge to make informed decisions and highlights how an expert-led approach can streamline your RWE initiatives.
🎧 This white paper is also available as an audiobook in multiple languages: English, German, French, Mandarin, and Spanish.